Vmbook Online ordering

Icons

**Company Information**

* **Company Name:** Icon Plc

* **Stock Symbol:** BAG-DASH

* **Exchange:** New York Stock Exchange (NYSE)

* **Industry:** Medical Device Manufacturing

**Business Overview**

Icon Plc is a global provider of clinical research services and solutions to the pharmaceutical, biotechnology, and medical device industries. The company offers a range of services, including clinical trial design, management, and data analysis, as well as regulatory consulting and staffing solutions.

**Earnings and Growth**

* **Revenue (2022):** $1.7 billion

* **Net Income (2022):** $182.4 million

* **Earnings Per Share (2022):** $2.66

* **Revenue Growth (2022):** 12.4%

* **Net Income Growth (2022):** 16.3%

**Financial Highlights**

* **Market Capitalization:** $4.2 billion

* **Trailing Price-to-Earnings Ratio (P/E):** 25.6

* **Dividend Yield:** 0.8%

* **Debt-to-Equity Ratio:** 0.2

**Key Metrics**

* **Number of Employees:** 17,000+

* **Global Presence:** 150+ countries

* **Therapeutic Areas:** Oncology, cardiovascular, neurology, infectious diseases, and rare diseases

**Recent Developments**

* Acquired PRA Health Sciences in 2021, expanding its global footprint and service offerings.

* Launched new digital health platform to enhance patient engagement and data collection.

* Collaborating with pharmaceutical companies on innovative clinical trial designs and technologies.

**Analyst Ratings**

* **Consensus Recommendation:** Buy

* **Median Price Target:** $110

**Risks**

* Competition from other clinical research organizations

* Dependence on pharmaceutical and biotechnology industry funding

* Regulatory changes and compliance requirements